Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma CofiledCriticalBristol Myers Squibb Pharma Co
Priority to MYPI0405126priorityCriticalpatent/MY141976A/en
Publication of MY141976ApublicationCriticalpatent/MY141976A/en
CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS OF FORMULA I OR II: AND THEIR USE IN TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC, NEUROLOGICAL DISORDERS AS WELL AS TREATMENT OF IMMUNOLOGICAL, CARDIOVASCULAR OR HEART-RELATED DISEASES AND COLONIC HYPERSENSITIVITY ASSOCIATED WITH PSYCHOPATHOLOGICAL DISTURBANCE AND STRESS.
MYPI04051261999-02-091999-02-09Azolo triazines and pyrimidines
MY141976A
(en)
4-(2-BUTYLAMINO-2, 7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-yl) PYRAZOLO-[1,5-a]-1,3,5-TRIAZINE, ITS ENANTIOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS AS CORTICOTROPIN RELEASING FACTOR RECEPTOR LIGANDS